Columbia University Irving Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Columbia University Irving Medical Center takes part in 2 sessions at ASH 2026 in New Orleans. Its program centres on AL amyloidosis and immune thrombocytopenia. It covers earlier diagnosis and shared management of AL amyloidosis, and real-world use of B-cell-directed therapies in ITP.
| Organization | ASH 2026 Attendance |
|---|---|
Columbia University Irving Medical Center New York, NY | |
Columbia University's academic medical center in New York City, home to its medical school and partnered with NewYork-Presbyterian Hospital. | Symposium Fri Dec 11 11:00am–2:00pm Actionable Approaches to AL Amyloidosis Care: Diagnosing Earlier, Treating Smarter, Managing Together Diagnosing light-chain amyloidosis earlier, personalizing treatment including fibril-targeting drugs, supporting patients, and improving team workflows. Symposium Fri Dec 11 7:00am–10:00am B-Cell–Directed Therapies in Immune Thrombocytopenia: Real-World Practice Newer B-cell-targeting treatments for immune thrombocytopenia and how to fit them into care to achieve lasting platelet responses. |
Instantly find 20 buyers from Columbia University Irving Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction